Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

Q1 2024 Ophthalmology Update

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Q1 2024 Ophthalmology Update

After a strong start to the year with two landmark, strategic transactions in January, the rest of the quarter slowed considerably with tepid deal flow in February and March. However, Provident expects transaction activity to rebound through the rest of the year, primarily driven by private-equity backed platforms exploring sale processes of their own. Many MSOs are between four and seven years into their respective hold periods and have begun to explore strategic options. As such, Provident expects the “consolidation of consolidators” theme to further play out towards the end of 2024 and into 2025. Former ASC management companies that have evolved into ASC and practice management partners have emerged as potential suitors for ophthalmology groups, as evidenced by Surgery Partners’ partnership with Key-Whitman Eye Center, as well as other deals that are rumored to be in the works. As the sector continues to mature, Provident expects more of these non-traditional buyers to enter the space via acquisition.

To print and download the full Ophthalmology Services Update report, please click below…

[holo_button icon=”/wp-content/uploads/2024/04/Q1-2024-Ophthalmology-Newsletter.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]